PGK1 and lung cancer: Similar to PGAM, targeting phosphoglycerate kinase 1 (PGK1) to inhibit glycolysis has become a new therapeutic target in tumor tissues through regulating inflammation (50, 54), and inhibition of PGK1 in macrophages can also reduce the production of inflammatory factors in lung cancer (55).